Skip to main content

Animations

MJFF Publications

5671 - 5680 of 9145 Results
Title
Year
  • Year
  • 2004
  • 2003
  • 2003
  • 2003
  • 2024
  • 2026
  • 2020
  • 2017
  • 2020
  • 2019
  • Summary Details
    OPEN
    Title: Lentiviral vector delivery of parkin prevents dopaminergic degeneration in an α-synuclein rat model of Parkinson's disease
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1073/pnas.0405313101
    Citation Count: 319
  • Summary Details
    OPEN
    Title: Differential regulation of midbrain dopaminergic neuron development by Wnt-1, Wnt-3a, and Wnt-5a
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1073/pnas.1534900100
    Citation Count: 369
  • Summary Details
    OPEN
    Title: Pitx3 is required for development of substantia nigra dopaminergic neurons
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1073/pnas.0230529100
    Citation Count: 388
  • Summary Details
    OPEN
    Title: Neuroectodermal differentiation from mouse multipotent adult progenitor cells
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1073/pnas.1834196100
    Citation Count: 348
  • Summary Details
    RESTRICTED
    Title: Mapping the human brain proteome: opportunities, challenges, and clinical potential
    Journal Name: Expert Review of Proteomics
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1080/14789450.2024.2313073
    Citation Count: 3
  • Summary Details
    OPEN
    Title: The pattern of fMRI activation with STN DBS reveals symptom-specific networks
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1038/s41531-026-01368-x
    Citation Count: 0
  • Summary Details
    OPEN
    Title: The impact of supine hypertension on target organ damage and survival in patients with synucleinopathies and neurogenic orthostatic hypotension
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.04.011
    Citation Count: 65
  • Summary Details
    OPEN
    Title: Drug repurposing to target proteostasis and prevent neurodegeneration: accelerating translational efforts
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/brain/awx107
    Citation Count: 20
  • Summary Details
    OPEN
    Title: Bidirectional gut-to-brain and brain-to-gut propagation of synucleinopathy in non-human primates
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/brain/awaa096
    Citation Count: 207
  • Summary Details
    OPEN
    Title: Age-dependent nigral dopaminergic neurodegeneration and α-synuclein accumulation in RGS6-deficient mice
    Journal Name: JCI Insight
    Publisher: American Society for Clinical Investigation
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1172/jci.insight.126769
    Citation Count: 29
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.